Octant
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1464 67th St, Emeryville, California, 94...Website
octant.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
1
About Octant
Octant is a synthetic-biology drug discovery company designing multi-target drug leads for multifactorial diseases. Octant engineers biology, using living cells as high-throughput data networks to map, measure and model compound reactions against GPCRs and ultimately, the entire universe of human receptors. Octant's novel polypharmacology discovery engine generates multi-receptor pathway data and predictive insights to inform rational drug design with unprecedented speed, scale and precision.Explore more
Octant Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Octant your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Octant has recently received funding, and reach out quickly before it becomes old news!
Octant, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Octant had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Octant launches new products
Website visits: Recent activity has been detected on your website
Check out if Octant is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Octant
Earning: See what the market has to say on Octant recently announced quarterly report
Funding: Get notified immidiatlly once Octant has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Octant
Compare insights from companies similar to Octant, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Octant is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Octant is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Octant.
Octant financials insights
Gather financial insights about Octant, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$30M
2022
Series B
$80M
Octant Tech Stack
A closer look at the technologies used by Octant
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Funding
Project
Octant News & Media
BMS joins Octant's $80M financing and signs on as a drug discovery partner - MedCity News
Octant Bio’s synthetic biology approach to drug discovery is making progress, and the preclinical biotech has raised $80 million in Series B financing to continue the journey. The company added Bristol Myers Squibb as an investor and collaborator in the search for new immunology drugs.Octant Raises $80 Million Series B Round to Support Expansion of Next-Generation Drug Discovery Platform, Announces Collaboration with Bristol Myers Squibb and Key Appointments
EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc. (“Octant” or the “Company”), a next-generation, data-driven therapeutics company developing programmable biology and chemistry to build precision medicines for complex diseases, today announced an $80 million Series B financing round led by Catalio Capital Management (“Catalio”), established a Deep Mutational Scanning (“DMS”) biopharma partnership with Bristol Myers Squibb, and appointed biotech industry veteran Dean “Rick” Artis as its first ChOctant Bio Appoints Industry Veteran Mark Murcko as Strategic Advisor and Board Member
EMERYVILLE, Calif.--(BUSINESS WIRE)--Today, Octant, a therapeutics company integrating novel high-throughput experimental technologies with computation to solve complex challenges in drug discovery, announced the appointment of Mark Murcko as Strategic Advisor and Board Member. Murcko brings over three decades of industry experience, having been at the center of many transformational biotech efforts, most recently as founding CSO and Board Member of Dewpoint Therapeutics. Murcko is working closGinkgo Bioworks and Octant Partner to Expand COVID-19 Testing Capacity using Next-Generation Sequencing Technology
BOSTON, Dec. 10, 2020 /PRNewswire/ -- Today, Ginkgo Bioworks, Inc. ("Ginkgo") and Octant, Inc ("Octant") announced a partnership to grow critical diagnostic testing capacity to address the COVID-19 pandemic, and build infrastructure to confront future health and biosecurity concerns. As...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Octant
Sign Up For FreeTo access detailed company insights
Octant is a synthetic-biology drug discovery company designing multi-target drug leads for multifactorial diseases. Octant engineers biology, using living cells as high-throughput data networks to map, measure and model compound reactions against GPCRs and ultimately, the entire universe of human receptors. Octant's novel polypharmacology discovery... Read More
